{"id":"W2965094856","doi":"10.1080/21645515.2019.1651141","title":"Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial","year":2019,"lang":"en","type":"article","venue":"Human Vaccines & Immunotherapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Immunogenicity; ELISPOT; Medicine; HBsAg; Placebo; Immunology; Adverse effect; Internal medicine; Cohort; Clinical trial; Virology; Vaccination; Hepatitis B virus; Immune system; Virus; T cell; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002011408,0.001438637,0.002150296,0.000424536,0.0004251587,0.0008177182,0.0007126293,0.002162312,0.004221657],"category_scores_gemma":[0.001491929,0.0004983169,0.001213038,0.0003439724,0.001185928,0.0008933767,0.0002775635,0.001808631,0.0007312312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004910268,"about_ca_system_score_gemma":0.0008837256,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002761903,"about_ca_topic_score_gemma":0.0004709433,"domain_scores_codex":[0.9993058,0.0003885115,0.00004737821,0.0001207447,0.00005447907,0.00008307178],"domain_scores_gemma":[0.9991761,0.000226059,0.000210543,0.00006737719,0.00006344647,0.0002563492],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9642864,0.01136426,0.0005104821,0.0005077677,0.0003104163,0.00003564788,0.00004355964,0.0002239628,0.005698444,0.00007836497,0.0004094444,0.0165313],"study_design_scores_gemma":[0.7989676,0.1977866,0.001578182,0.00002957386,0.0001770919,0.00003296043,0.00001496984,0.0002798074,0.0005970716,0.00008024495,0.0004446099,0.00001125412],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915175,0.003363187,0.0005484553,0.0004869087,0.0002841626,0.002422925,0.0004334558,0.00009815221,0.0008453458],"genre_scores_gemma":[0.9904448,0.001836782,0.001278681,0.0009416373,0.0004090167,0.003230985,0.0006392755,0.00001649259,0.001202335],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004221657,"threshold_uncertainty_score":0.01412284,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01536005886177466,"score_gpt":0.2917780412803101,"score_spread":0.2764179824185354,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}